Rheumatoid arthritis (RA) is the most common autoimmune inflammatory arthritis in adults. In June, the ACR released an updated guideline on the management of rheumatoid arthritis.1 The guideline includes 44 recommendations—seven of which are strong and 37 conditional. It underscores the role of methotrexate as a cornerstone therapy and emphasizes minimizing glucocorticoids, when possible. It also includes new recommendations for specific high-risk groups. Learn more in our article below.
Plus, a vast repository of new research related to RA is slated for presentation at ACR Convergence 2021. Come back soon to see what abstracts Jeffrey Curtis, MD, MS, MPH, considers the most likely to make an impact on clinical practice and future research. Review the top research presented during ACR Convergence 2020 selected by Elizabeth (Blair) Solow, MD, an assistant professor of medicine in the Division of Rheumatic Diseases at UT Southwestern Medical Center, Dallas.